Advertisement

Topics

Latest "Ghirardelli Chocolate Company" News Stories

16:44 EDT 25th September 2018 | BioPortfolio

Here are the most relevant search results for "Ghirardelli Chocolate Company" found in our extensive news archives from over 250 global news sources.

More Information about Ghirardelli Chocolate Company on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Ghirardelli Chocolate Company for you to read. Along with our medical data and news we also list Ghirardelli Chocolate Company Clinical Trials, which are updated daily. BioPortfolio also has a large database of Ghirardelli Chocolate Company Companies for you to search.

Showing "Ghirardelli Chocolate Company" News Articles 1–25 of 16,000+

Tuesday 25th September 2018

MusclePharm Corporation to Present at The MicroCap Conference on October 2, 2018

BURBANK, CA / ACCESSWIRE / September 25, 2018 / MusclePharm® Corporation (OTCQB: MSLP) ("MusclePharm" or the "Company"), a scientifically driven, performance-lifestyle sports nutrition company, ann...


Alexion to Present at the Leerink Partners Roundtable Series: Rare Disease & Oncology

Alexion Pharmaceuticals (Nasdaq: ALXN) today announced that management will present at the Leerink Partners Roundtable Series: Rare Disease & Oncology in New York, NY on Tuesday, October 2, 2018 at 10 a.m., EDT. An audio webcast of the presentation will be available live. You can access the webcast at: http://ir.alexion.com. An archived versio...

Zymeworks to Present at Ladenburg Thalmann 2018 Healthcare Conference

Zymeworks Inc. (NYSE/TSX: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced that management will present at the upcoming Ladenburg Thalmann 2018 Healthcare Conference taking place October 1-2, 2018 in New York, NY. The Company will provide a corporate update on Tuesday, October 2, 2018 ...


Ra Pharmaceuticals to Present at the 2018 Cantor Global Healthcare Conference

Ra Pharmaceuticals, Inc. (Nasdaq:RARX) today announced that Doug Treco, PhD, President and Chief Executive Officer of Ra Pharma, will present at the 2018 Cantor Global Healthcare Conference on Tuesday, October 2, 2018 at 9:10 a.m. E.T. The conference is being held at the InterContinental New York Barclay Hotel. The presentation will be webcast liv...

Synlogic to Webcast Presentation at the Leerink Partners Roundtable Series: Rare Disease & Oncology

Synlogic (Nasdaq:SYBX) announced today that Aoife Brennan, M.B., B.Ch., Synlogic’s interim president and chief executive officer, and chief medical officer, will present a corporate update at the Leerink Partners Roundtable Series on Rare Diseases and Oncology at 11:30 am ET on Tuesday, October 2, 2018, in New York City. A live webcast of...

Protea Biosciences Group Inc PRGB Medical Equipment Deals and Alliances Profile [Report Updated: 12072018] Prices from USD $250

SummaryProtea Biosciences Group Inc Protea is a biotechnology company that develops mass spectometry solutions. The company offers technology for the characterization, identification, and quantitation of biologicallyimportant molecules for research, pharmaceutical development, and diagnostic applications. Its products include protein sample preparation, functionalized pipette tips and plates, gel ...

Takeda to Present Positive Data from Alunbrig Trial Showing a Reduction in Risk of Disease Progression or Death of More Than 50% Versus Crizotinib in Advanced ALK+ NSCLC

CAMBRIDGE, Mass. & OSAKA, Japan–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited (TSE: 4502) today announced results from the Phase 3 ALTA-1L (ALK in Lung Cancer Trial of BrigAtinib in 1st Line) trial, demonstrating that ALUNBRIG reduced the risk of disease progression or death, known as progression-free survival (PFS), as assessed by a blinded independent review committee...

Pluristem Therapeutics Announces FDA Orphan Drug Designation for PLX cell therapy

Pluristem Therapeutics (Nasdaq:PSTI) (TASE:PSTI), a leading regenerative medicine company developing novel placenta-based cell therapy products, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to the Company’s PLX cell therapy for the treatment of graft failure and incomplete hematopoietic recovery following hematopoietic cell transplantation...

. @Novartis CEO Vas Narasimhan Announces Company Eliminating 2,000+ Jobs in U.K., Switzerland: http://ow.ly/5Iwv30lXQpe pic.twitter.com/GDq9uwqDv8

. @Novartis CEO Vas Narasimhan Announces Company Eliminating 2,000+ Jobs in U.K., Switzerland: http://ow.ly/5Iwv30lXQpe  pic.twitter.com/GDq9uwqDv8

Cannabis Oil Producer Halo Labs Provides Business Update

Common shares are expected to commence trading under the symbol "HALO" Halo Labs Inc.: NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Apogee Opportunities Inc. (to be renamed Halo Labs Inc.) ("Halo" or the "Company") is pleased to provide a corporate and ...

FDA Approves Verastem’s Copiktra for Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

BOSTON–(BUSINESS WIRE)–Verastem, Inc. (Nasdaq:VSTM) (Verastem Oncology or the Company), focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients, today announced that the U.S. Food and Drug Administration (FDA) has approved COPIKTRA™, an oral inhibitor of phosphoinositide 3-kinase (PI3K), and the first approved dual inhibitor ...

Cantrell Drug Company Resumes Operations with FDA Approval

Dr. James L. McCarley, Jr., Chairman and CEO of Cantrell Drug Company, https://cantrelldrug.com/, a 503B Registered Outsourcing Facility, announced that his Company has received final approval from the FDA to begin producing and shipping product under the terms and conditions of a Consent Decree Agreement with the FDA that was signed on April 19th of this year. ...

Harvest, A Fully Vertically Integrated Cannabis Company With One of the Largest Footprints in the US, Announces Latest License Win in North Dakota

Now Holding More than 40 Licenses, Harvest Continues to Expand across North America Harvest Enterprises Inc., a vertically integrated cannabis company with one of the largest footprints in the United States and growing at a robust pace, today announced that its North Dakota affiliate has been awarded a retail license for the Bismarck-M...

Philadelphia Insurance Donates $350,000 to American Diabetes Association® Camps

Nearly 18,000 children are diagnosed with type 1 diabetes each year. PHLY employees voted to support ADA Camps to help empower kids living with the disease. BALA CYNWYD, Pa. (PRWEB) September 25, 2018 Children battling diabetes need to manage it 24/7 and sometimes feel isolated from peers, who don’t understand what it’s like to deal with the disease. Employees at Philadelphia Insurance Compan...

Acacia Pharma Group plc: Results of General Meeting

Cambridge, UK - 25 September 2018- Acacia Pharma Group plc (the "Company") (Euronext: ACPH) is pleased to announce that both resolutions as set out in the Notice of General Meeting dated 7 September 2018 were duly passed by the required majority at the General Meeting held earlier today. The results of the votes on the resolutions are shown in the table below and will be...

Klick Health’s Incubated Startup, Circulation, Announces Successful Exit

Agency’s commercialization practice thriving as it continues to introducenew healthcare innovation and modern business models Klick Health’s growing commercialization partner portfolio is proud of the successful exit of Circulation, one of Klick’s first incubation initiatives. Circulation has

Anthem Blue Cross Teams Up with Imperial Health to Offer a Medicare Advantage Plan

Collaboration will give consumers healthcare services through network of care providers committed to delivering quality care Anthem Blue Cross (Anthem) announced it will expand on its commitment to providing Medicare-eligible consumers high-quality, affordable healthcare through a collaboration with Imperial Health Holdings Medical Group. The joint eff...

Tandem Diabetes Care Increases 2018 Sales Guidance and Provides Estimated Third Quarter Sales Results

Continued Domestic Demand and International Launch of the t:slim X2 Insulin Pump Drive Growth Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps with continuous glucose monitoring integration, today announced that it has increased its 2018 sales guidance to $150 million...

LabCorp to Announce Third Quarter Financial Results on October 24, 2018

LabCorp® (NYSE: LH) will release its third quarter 2018 financial results before the market opens on Wednesday, October 24, 2018, and then will host a conference call and webcast beginning at 9:00 a.m. EDT to discuss the results. The earnings release and accompanying financial information will be posted on the LabCorp Investor Relations website. ...

$TGTX Update Regarding UNITY-CLL Phase 3 Trial. DSMB advised the Company that the interim analysis of ORR could not be conducted at this time as the data were not sufficiently mature https://finance.yahoo.com/news/tg-therapeutics-announces-regarding-unity

$TGTX Update Regarding UNITY-CLL Phase 3 Trial. DSMB advised the Company that the interim analysis of ORR could not be conducted at this time as the data were not sufficiently mature https://finance.yahoo.com/news/tg-therapeutics-announces-regarding-unity-110000280.html …

COMPANY REMAINS BLINDED TO ALL EFFICACY DATA $TGTX

COMPANY REMAINS BLINDED TO ALL EFFICACY DATA $TGTX

Catabasis Pharmaceuticals Initiates Phase 3 PolarisDMD Clinical Trial for Edasalonexent in Duchenne Muscular Dystrophy

-- Pivotal Study of Novel Inhibitor of NF-kB, a Key Driver of Skeletal Muscle Disease and Cardiomyopathy in Duchenne -- Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, today announced the initiation of Po

Millendo Therapeutics Appoints Habib Dable to Its Board of Directors

Millendo Therapeutics, Inc., a clinical-stage biotechnology company developing novel therapies for orphan endocrine diseases, today announced the appointment of Habib Dable, President and Chief Executive Officer of Acceleron Pharma Inc., to the Company’s Board of Directors. “Habib brings to our board an exceptional mix of executive and ...

Relay Medical To Commence Trading in United States as RYMDF

Relay Medical Corp. (CSE:RELA) (OTCQB:RYMDF) (FSE: EIY2) ("Relay" or the "Company"), an engine of MedTech innovation, is pleased to provide an update on the Company's trading status in the United States. The post Relay Medical To Commence Trading in United States as RYMDF appeared first on Investing News Network.

Ra Pharma Elects Aoife M. Brennan, M.B., B.Ch., to Board of Directors

Ra Pharmaceuticals, Inc. (Nasdaq:RARX) today announced the election of Aoife M. Brennan, M.B., B.Ch., to its board of directors. “Dr. Brennan has an impressive track record of success in advancing the development of numerous drug candidates throughout her career, with experience in the fields of rare disease, hematology, and neurology, among oth...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks